BostonGene has raised a total of $386 million in funding from investors such as SoftBank Vision Fund 2, Eldridge, and Tiger Global Management. The company’s mission is to revolutionize precision medicine by integrating molecular profiling, analytics, and artificial intelligence to tailor treatments for individual cancer patients.
What Is BostonGene and What Does It Do?
BostonGene, founded in 2015 by Andrew Feinberg, is headquartered in Waltham, Massachusetts. The company develops an AI-powered molecular and immune profiling platform that transforms how cancer and immune-related diseases are diagnosed and treated.
By combining genomic data, advanced analytics, and machine learning, BostonGene provides oncologists with a comprehensive view of a patient’s tumor biology to guide personalized therapy decisions. Its technology enables clinicians to predict treatment responses, select optimal therapies, and improve patient outcomes through precision oncology.
With a team of 46 employees (as of December 31, 2022), BostonGene is redefining the future of cancer treatment by bridging the gap between complex molecular data and actionable clinical insights.
How Much Funding Has BostonGene Raised?
1. Series A
- Amount Raised: $150 million
- Date: August 2020
- Lead Investors: SoftBank Vision Fund 2
- Motivation: To accelerate the commercialization of its AI-driven molecular analytics platform and expand research partnerships.
2. Series B
- Amount Raised: $200 million
- Date: November 2024
- Lead Investors: Eldridge, Tiger Global Management
- Motivation: To scale global operations, advance clinical adoption, and enhance precision oncology solutions using AI and big data.
Total Funding Raised: $386 Million
Current Valuation: $1 Billion (as of Apr 2022)
Latest Funding Date: November 2024
Key Investors
1. SoftBank Vision Fund 2
- Details: A leading global technology investment fund managed by SoftBank Investment Advisers.
- Investment Focus Areas: AI, robotics, digital health, and next-generation enterprise software.
- Notable Investments: WeWork, Cruise, and BostonGene.
2. Eldridge
- Details: A diversified holding company with investments in insurance, asset management, technology, and healthcare.
- Investment Focus Areas: Fintech, healthcare innovation, and media.
- Notable Investments: SecurityScorecard, Dataminr, and BostonGene.
3. Tiger Global Management
- Details: A global investment firm focusing on public and private technology companies.
- Investment Focus Areas: SaaS, healthcare technology, and AI-powered platforms.
- Notable Investments: Stripe, Databricks, and BostonGene.
Where Is BostonGene’s Headquarters?
BostonGene is headquartered in Waltham, Massachusetts, a major hub for biotech and life sciences innovation. This location gives the company access to world-class research institutions, top medical centers, and a strong talent pool in biotechnology and computational medicine.
What’s Next for BostonGene?
BostonGene aims to expand its precision medicine platform globally, enhance AI-driven diagnostics, and strengthen collaborations with leading hospitals and research institutions. The company is also focused on integrating real-world data analytics to personalize cancer treatments further, helping clinicians make faster, more effective decisions in oncology care.
Get Investor & Funding Insights with TexAu
TexAu helps sales and business teams uncover detailed fundraising information on companies like BostonGene. Use the platform to research investors, track funding rounds, and gather actionable insights to strengthen prospecting and business strategy.
Sign Up for Free on TexAu and start uncovering detailed funding insights that give your business a competitive edge.
